StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note issued to investors on Thursday morning. The firm issued a hold rating on the stock.
China Pharma Price Performance
Shares of NYSE CPHI opened at $0.22 on Thursday. The firm’s 50-day moving average price is $0.21 and its 200-day moving average price is $0.28. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.24 and a current ratio of 0.84. China Pharma has a 12-month low of $0.17 and a 12-month high of $1.21.
China Pharma (NYSE:CPHI – Get Free Report) last announced its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $0.93 million for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Articles
- Five stocks we like better than China Pharma
- Most active stocks: Dollar volume vs share volume
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- When to Sell a Stock for Profit or Loss
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
